| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;107:2185.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Ga.
Correspondence to Earl Ford, MD, MPH, Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K66, Atlanta, GA 30341. E-mail EFord{at}cdc.gov
Background Serum cholesterol concentrations have decreased in the US population. Whether the decline continued during the 1990s is unknown.
Methods and Results We used data from 4148 men and women aged
20 years who had a total cholesterol determination or reported using cholesterol-lowering medications and who participated in the National Health and Nutrition Examination Survey (NHANES) from 1999 to 2000 (this is a cross-sectional health examination survey of the US population), and we compared the results with data from 15 719 participants in NHANES III (1988 to 1994). For all adults, the age-adjusted mean total cholesterol concentration decreased from 5.31 mmol/L (205 mg/dL) in NHANES III to 5.27 mmol/L (203 mg/dL) in NHANES 1999 to 2000 (P=0.159). The age-adjusted mean total cholesterol concentration decreased by 0.02 mmol/L (0.7 mg/dL) among men (P=0.605) and 0.06 mmol/L (2.3 mg/dL) among women (P=0.130). Significant decreases were observed among men aged
75 years, black men, and Mexican-American women. Among participants who had a total cholesterol concentration
5.2 mmol/L (200 mg/dL) or who reported using cholesterol-lowering medications, 69.5% reported having had their cholesterol checked, 35.0% were aware that they had hypercholesterolemia, 12.0% were on treatment, and 5.4% had a total cholesterol concentration <5.2 mmol/L (200 mg/dL) after age adjustment.
Conclusions The mean serum total cholesterol concentration of the adult US population in 1999 to 2000 has changed little since 1988 to 1994. The low percentage of adults with controlled blood cholesterol concentration suggests the need for a renewed commitment to the prevention, treatment, and control of hypercholesterolemia.
Key Words: cholesterol hypercholesterolemia population sex risk factors
This article has been cited by other articles:
![]() |
M. D. Solomon, D. P. Goldman, G. F. Joyce, and J. J. Escarce Cost Sharing and the Initiation of Drug Therapy for the Chronically Ill Arch Intern Med, April 27, 2009; 169(8): 740 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McWilliams, E. Meara, A. M. Zaslavsky, and J. Z. Ayanian Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage Ann Intern Med, April 21, 2009; 150(8): 505 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. Gwynn, R. K. Garg, B. D. Kerker, T. R. Frieden, and L. E. Thorpe Contributions of a Local Health Examination Survey to the Surveillance of Chronic and Infectious Diseases in New York City Am J Public Health, January 1, 2009; 99(1): 152 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Puglisi and M. L. Fernandez Modulation of C-Reactive Protein, Tumor Necrosis Factor-{alpha}, and Adiponectin by Diet, Exercise, and Weight Loss J. Nutr., December 1, 2008; 138(12): 2293 - 2296. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mann, K. Reynolds, D. Smith, and P. Muntner Trends in Statin Use and Low-Density Lipoprotein Cholesterol Levels Among US Adults: Impact of the 2001 National Cholesterol Education Program Guidelines Ann. Pharmacother., September 1, 2008; 42(9): 1208 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Jacobson Toward 'Pain-Free' Statin Prescribing: Clinical Algorithm for Diagnosis and Management of Myalgia Mayo Clin. Proc., June 1, 2008; 83(6): 687 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Geller, S. Cassens, M. Brosz, U. Keil, J. Bernarding, S. Kropf, R. A. Bierwirth, B. Lippmann-Grob, H.-P. Schultheiss, K. Schluter, et al. Achievement of guideline-defined treatment goals in primary care: the German Coronary Risk Management (CoRiMa) study Eur. Heart J., December 2, 2007; 28(24): 3051 - 3058. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Ford and S. Capewell Coronary Heart Disease Mortality Among Young Adults in the U.S. From 1980 Through 2002: Concealed Leveling of Mortality Rates J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2128 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. F. Green Summary of Workgroup Meeting on Use of Family History Information in Pediatric Primary Care and Public Health Pediatrics, September 1, 2007; 120(SUPPLEMENT_2): S87 - S100. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Ford, U. A. Ajani, J. B. Croft, J. A. Critchley, D. R. Labarthe, T. E. Kottke, W. H. Giles, and S. Capewell Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980-2000 N. Engl. J. Med., June 7, 2007; 356(23): 2388 - 2398. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Keevil, M. W. Cullen, R. Gangnon, P. E. McBride, and J. H. Stein Implications of Cardiac Risk and Low-Density Lipoprotein Cholesterol Distributions in the United States for the Diagnosis and Treatment of Dyslipidemia: Data From National Health and Nutrition Examination Survey 1999 to 2002 Circulation, March 20, 2007; 115(11): 1363 - 1370. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Pearson The Prevention Of Cardiovascular Disease: Have We Really Made Progress? Health Aff., January 1, 2007; 26(1): 49 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kashani, C. O. Phillips, J. M. Foody, Y. Wang, S. Mangalmurti, D. T. Ko, and H. M. Krumholz Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials Circulation, December 19, 2006; 114(25): 2788 - 2797. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanjilal, E. W. Gregg, Y. J. Cheng, P. Zhang, D. E. Nelson, G. Mensah, and G. L. A. Beckles Socioeconomic Status and Trends in Disparities in 4 Major Risk Factors for Cardiovascular Disease Among US Adults, 1971-2002 Arch Intern Med, November 27, 2006; 166(21): 2348 - 2355. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mittleman A 39-year-old woman with hypercholesterolemia. JAMA, July 19, 2006; 296(3): 319 - 326. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Lloyd-Jones and L. Tian Predicting cardiovascular risk: so what do we do now? Arch Intern Med, July 10, 2006; 166(13): 1342 - 1344. [Full Text] [PDF] |
||||
![]() |
P. Muntner, K. B. DeSalvo, R. P. Wildman, P. Raggi, J. He, and P. K. Whelton Trends in the Prevalence, Awareness, Treatment, and Control of Cardiovascular Disease Risk Factors among Noninstitutionalized Patients with a History of Myocardial Infarction and Stroke Am. J. Epidemiol., May 15, 2006; 163(10): 913 - 920. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Goldman, D. R. Parker, C. B. Eaton, J. M. Borkan, R. Gramling, R. T. Cover, and D. K. Ahern Patients' Perceptions of Cholesterol, Cardiovascular Disease Risk, and Risk Communication Strategies Ann. Fam. Med, May 1, 2006; 4(3): 205 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rodondi, T. Peng, A. J. Karter, D. C. Bauer, E. Vittinghoff, S. Tang, D. Pettitt, E. A. Kerr, and J. V. Selby Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus Ann Intern Med, April 4, 2006; 144(7): 475 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Yang, L. D. Botto, J. D. Erickson, R. J. Berry, C. Sambell, H. Johansen, and J.M. Friedman Improvement in Stroke Mortality in Canada and the United States, 1990 to 2002 Circulation, March 14, 2006; 113(10): 1335 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. B. Eaton, J. M. Galliher, P. E. McBride, A. J. Bonham, J. A. Kappus, and J. Hickner Family Physician's Knowledge, Beliefs, and Self-reported Practice Patterns Regarding Hyperlipidemia: A National Research Network (NRN) Survey J Am Board Fam Med, January 1, 2006; 19(1): 46 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Arnett, D. R. Jacobs Jr, R. V. Luepker, H. Blackburn, C. Armstrong, and S. A. Claas Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980-1982 to 2000-2002 Circulation, December 20, 2005; 112(25): 3884 - 3891. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bushe and C. Paton The potential impact of antipsychotics on lipids in schizophrenia: is there enough evidence to confirm a link? J Psychopharmacol, November 1, 2005; 19(6_suppl): 76 - 83. [Abstract] [PDF] |
||||
![]() |
M. D. Carroll, D. A. Lacher, P. D. Sorlie, J. I. Cleeman, D. J. Gordon, M. Wolz, S. M. Grundy, and C. L. Johnson Trends in Serum Lipids and Lipoproteins of Adults, 1960-2002 JAMA, October 12, 2005; 294(14): 1773 - 1781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. McKenney Efficacy and safety of rosuvastatin in treatment of dyslipidemia Am. J. Health Syst. Pharm., May 15, 2005; 62(10): 1033 - 1047. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ostbye, K. S. H. Yarnall, K. M. Krause, K. I. Pollak, M. Gradison, and J. L. Michener Is There Time for Management of Patients With Chronic Diseases in Primary Care? Ann. Fam. Med, May 1, 2005; 3(3): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Wadwa, G. L. Kinney, D. M. Maahs, J. Snell-Bergeon, J. E. Hokanson, S. K. Garg, R. H. Eckel, and M. Rewers Awareness and Treatment of Dyslipidemia in Young Adults With Type 1 Diabetes Diabetes Care, May 1, 2005; 28(5): 1051 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Levy and T. A. Pearson Commentary J Gerontol A Biol Sci Med Sci, May 1, 2005; 60(5): 597 - 598. [Full Text] [PDF] |
||||
![]() |
T. A. Pearson, M. A. Denke, P. E. McBride, W. P. Battisti, W. E. Brady, and J. Palmisano A Community-Based, Randomized Trial of Ezetimibe Added to Statin Therapy to Attain NCEP ATP III Goals for LDL Cholesterol in Hypercholesterolemic Patients: The Ezetimibe Add-On to Statin for Effectiveness (EASE) Trial Mayo Clin. Proc., May 1, 2005; 80(5): 587 - 595. [Abstract] [PDF] |
||||
![]() |
M. C. Costanza, E. Cayanis, B. M. Ross, M. S. Flaherty, G. B. Alvin, K. Das, and A. Morabia Relative Contributions of Genes, Environment, and Interactions to Blood Lipid Concentrations in a General Adult Population Am. J. Epidemiol., April 15, 2005; 161(8): 714 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
Racial/Ethnic and Socioeconomic Disparities in Multiple Risk Factors for Heart Disease and Stroke--United States, 2003 JAMA, March 23, 2005; 293(12): 1441 - 1443. [Full Text] [PDF] |
||||
![]() |
R. S. Vasan, L. M. Sullivan, P. W.F. Wilson, C. T. Sempos, J. Sundstrom, W. B. Kannel, D. Levy, and R. B. D'Agostino Relative Importance of Borderline and Elevated Levels of Coronary Heart Disease Risk Factors Ann Intern Med, March 15, 2005; 142(6): 393 - 402. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Mulrow and W. Kussmaul The Middle-Aged and Older American: Wrong Prototype for a Preventive Polypill? Ann Intern Med, March 15, 2005; 142(6): 467 - 468. [Full Text] [PDF] |
||||
![]() |
E. J. Benjamin, M. Jessup, J. M. Flack, H. M. Krumholz, K. Liu, V. M. Nadkarni, D. A. Rhoades, B. L. Rodriguez, R. P. Scott, M. P. Taylor, et al. Discovering the Full Spectrum of Cardiovascular Disease: Minority Health Summit 2003: Report of the Outcomes Writing Group Circulation, March 15, 2005; 111(10): e124 - e133. [Full Text] [PDF] |
||||
![]() |
R. S. Vasan and R. B. D'Agostino Sr Age and Time Need Not and Should Not Be Eliminated From the Coronary Risk Prediction Models Circulation, February 8, 2005; 111(5): 542 - 545. [Full Text] [PDF] |
||||
![]() |
L. Mosca, N. B. Merz, R. S. Blumenthal, M. J. Cziraky, R. P. Fabunmi, C. Sarawate, K. E. Watson, V. J. Willey, and E. J. Stanek Opportunity for Intervention to Achieve American Heart Association Guidelines for Optimal Lipid Levels in High-Risk Women in a Managed Care Setting Circulation, February 1, 2005; 111(4): 488 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Mosca, A. H. Linfante, E. J. Benjamin, K. Berra, S. N. Hayes, B. W. Walsh, R. P. Fabunmi, J. Kwan, T. Mills, and S. L. Simpson National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines Circulation, February 1, 2005; 111(4): 499 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Frieden Asleep at the Switch: Local Public Health and Chronic Disease Am J Public Health, December 1, 2004; 94(12): 2059 - 2061. [Full Text] [PDF] |
||||
![]() |
E. S. Ford, A. H. Mokdad, and U. A. Ajani Trends in Risk Factors for Cardiovascular Disease Among Children and Adolescents in the United States Pediatrics, December 1, 2004; 114(6): 1534 - 1544. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Greenlund, J. B. Croft, and G. A. Mensah Prevalence of Heart Disease and Stroke Risk Factors in Persons With Prehypertension in the United States, 1999-2000 Arch Intern Med, October 25, 2004; 164(19): 2113 - 2118. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Ford, W. H. Giles, and A. H. Mokdad Increasing Prevalence of the Metabolic Syndrome Among U.S. Adults Diabetes Care, October 1, 2004; 27(10): 2444 - 2449. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Imperatore, B. L. Cadwell, L. Geiss, J. B. Saadinne, D. E. Williams, E. S. Ford, T. J. Thompson, K. M. Venkat Narayan, and E. W. Gregg Thirty-year Trends in Cardiovascular Risk Factor Levels among US Adults with Diabetes: National Health and Nutrition Examination Surveys, 1971-2000 Am. J. Epidemiol., September 15, 2004; 160(6): 531 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Krumholz The year in health care delivery and outcomes research J. Am. Coll. Cardiol., September 1, 2004; 44(5): 1130 - 1136. [Full Text] [PDF] |
||||
![]() |
J. He, D. Gu, K. Reynolds, X. Wu, P. Muntner, J. Zhao, J. Chen, D. Liu, J. Mo, P. K. Whelton, et al. Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China Circulation, July 27, 2004; 110(4): 405 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Glynn, N. R. Cook, P. Libby, J. T. Willerson, E. Braunwald, J. M. Foody, A. M. Gotto, N. Wenger, P. M. Ridker, W. Koenig, et al. C-Reactive Protein and Coronary Heart Disease N. Engl. J. Med., July 15, 2004; 351(3): 295 - 298. [Full Text] [PDF] |
||||
![]() |
J. O'Loughlin, B. Lauzon, G. Paradis, J. Hanley, E. Levy, E. Delvin, and M. Lambert Usefulness of the American Academy of Pediatrics Recommendations for Identifying Youths With Hypercholesterolemia Pediatrics, June 1, 2004; 113(6): 1723 - 1727. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Ford, W. H. Giles, and A. H. Mokdad The distribution of 10-Year risk for coronary heart disease among U.S. adults: Findings from the National Health and Nutrition Examination Survey III J. Am. Coll. Cardiol., May 19, 2004; 43(10): 1791 - 1796. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. T. Ko, M. Mamdani, and D. A. Alter Lipid-Lowering Therapy With Statins in High-Risk Elderly Patients: The Treatment-Risk Paradox JAMA, April 21, 2004; 291(15): 1864 - 1870. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Topol Intensive Statin Therapy -- A Sea Change in Cardiovascular Prevention N. Engl. J. Med., April 8, 2004; 350(15): 1562 - 1564. [Full Text] [PDF] |
||||
![]() |
A. H. Mokdad, J. S. Marks, D. F. Stroup, and J. L. Gerberding Actual Causes of Death in the United States, 2000 JAMA, March 10, 2004; 291(10): 1238 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Folsom, E. S. Ford, A. H. Mokdad, W. H. Giles, and G. A. Mensah Serum Total Cholesterol Concentrations and Awareness, Treatment, and Control of Hypercholesterolemia Among US Adults * Response Circulation, November 25, 2003; 108 (21): e152 - e152. [Full Text] [PDF] |
||||
![]() |
The People vs. High Cholesterol: What's the Verdict? Journal Watch Cardiology, June 27, 2003; 2003(627): 1 - 1. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |